These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2790100)

  • 1. Salbutamol psychosis.
    Whitehouse AM; Novosel S
    Biol Psychiatry; 1989 Oct; 26(6):631-3. PubMed ID: 2790100
    [No Abstract]   [Full Text] [Related]  

  • 2. Exacerbation of psychosis associated with inhaled albuterol.
    Martin W; Unützer J; Szuba MP
    J Clin Psychopharmacol; 1995 Dec; 15(6):446-7. PubMed ID: 8748438
    [No Abstract]   [Full Text] [Related]  

  • 3. Paranoid psychosis with Ventolin (salbutamol tablets b.p.).
    Ray I; Evans CJ
    Can Psychiatr Assoc J; 1978 Oct; 23(6):427. PubMed ID: 709492
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose response to inhaled salbutamol in chronic obstructive airways disease.
    Teale C; Morrison JF; Page RL; Pearson SB
    Postgrad Med J; 1991 Aug; 67(790):754-6. PubMed ID: 1754527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Salbutamol in the treatment of functional broncho-obstructive syndromes].
    Fiora L
    Minerva Med; 1976 Apr; 67(17):1165-75. PubMed ID: 1264395
    [No Abstract]   [Full Text] [Related]  

  • 6. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
    Ikeda A; Nishimura K; Izumi T
    Chest; 1996 Jan; 109(1):294. PubMed ID: 8549208
    [No Abstract]   [Full Text] [Related]  

  • 7. [Becotide rotadisks 0.1 mg/0.2 mg/0.4 mg and sultanol rotadisks 0.2 mg/0.4 mg, powder for dry inhalation with the Diskhaler].
    Nanz S
    Wien Klin Wochenschr; 1993; 105(11):330-3. PubMed ID: 8333201
    [No Abstract]   [Full Text] [Related]  

  • 8. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
    Ingram RH
    Chest; 1996 Jan; 109(1):293. PubMed ID: 8549206
    [No Abstract]   [Full Text] [Related]  

  • 9. Tolerance to beta 2-agonists in patients with chronic obstructive pulmonary disease.
    Georgopoulos D; Wong D; Anthonisen NR
    Chest; 1990 Feb; 97(2):280-4. PubMed ID: 1967572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease.
    Crane J; Burgess CD; Graham AN; Maling TJ
    N Z Med J; 1987 May; 100(824):309-11. PubMed ID: 3330186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience with delayed-action salbutamol].
    Zanotelli F
    Minerva Med; 1976 Mar; 67(16):1019-22. PubMed ID: 1264374
    [No Abstract]   [Full Text] [Related]  

  • 12. Salbutamol and cardiac arrhythmias.
    Crawford SM; Miles DW
    Curr Med Res Opin; 1981; 7(6):410-5. PubMed ID: 7238086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of salbutamol on oxygen saturation in COPD.
    Charoenratanakul S; Borrirukwanit K
    J Med Assoc Thai; 1996 Apr; 79(4):218-21. PubMed ID: 8708506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiences with large doses of beta 2-agonists inhaled from nebulizers.
    Larsson S
    Postgrad Med J; 1983; 59 Suppl 3():71-2. PubMed ID: 6647211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of inhaled salbutamol on pulmonary gas exchange in patients with chronic obstructive bronchopneumopathy].
    Clerbaux T; Henry P; Veriter C; Nullens W; Detry B; Cao ML; Raphael D; Frans A
    Rev Mal Respir; 1992; 9(2):171-7. PubMed ID: 1565829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of salbutamol in patients with chronic obstructive lung disease (author's transl)].
    Pasquis P; Nouvet G; Denis P; David P; Lefrançois R; Morère P
    Therapie; 1981; 36(1):81-5. PubMed ID: 7233376
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute carbon dioxide narcosis during inhalational therapy with oxygen powered nebulizers in patients with chronic airflow limitation.
    Lim TK; Tan WC
    Ann Acad Med Singap; 1985 Jul; 14(3):439-41. PubMed ID: 4073810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response study of inhaled salbutamol powder in chronic airflow obstruction.
    Corris PA; Neville E; Nariman S; Gibson GJ
    Thorax; 1983 Apr; 38(4):292-6. PubMed ID: 6867983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinico-pharmacologic study of a new sustained-release oral salbutamol preparation in patients with obstructive airway disease].
    Bauer K; Lorenz PR; Seibel K; Neiss A; Eandi M; Kaik G
    Arzneimittelforschung; 1989 Jul; 39(7):801-4. PubMed ID: 2675854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients.
    Dhand R; Duarte AG; Jubran A; Jenne JW; Fink JB; Fahey PJ; Tobin MJ
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):388-93. PubMed ID: 8756811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.